Yazan Alwarawrah
Affiliations: | 2012-2016 | Pharmacology | Duke University, Durham, NC |
Google:
"Yazan Alwarawrah"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kulkarni MM, Ratcliff AN, Bhat M, et al. (2017) Cellular fatty acid synthase is required for late stages of HIV-1 replication. Retrovirology. 14: 45 |
| Spector NL, Haystead T, Zhao S, et al. (2017) Abstract 2219: Cancer prevention using a novel fatty acid synthase inhibitor Cancer Research. 77: 2219-2219 |
| Alwarawrah Y, Hughes P, Loiselle D, et al. (2016) Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer. Cell Chemical Biology |
| Darr D, Alwarawrah Y, Hunter L, et al. (2015) Abstract 4457: Novel fatty-acid synthase inhibitor in combination with platinum-based therapy provides increased tumor killing efficacy in luminal breast murine model Cancer Research. 75: 4457-4457 |
| Alwarawrah Y, Hughes P, Safi R, et al. (2015) Abstract 2703: Overcoming Lapatinib resistance by the fatty acid synthase inhibitor HS-106 Cancer Research. 75: 2703-2703 |
| Howe MK, Bodoor K, Carlson DA, et al. (2014) Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70. Chemistry & Biology. 21: 1648-59 |